Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 6.33% vs -11.53% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 40.09% vs 0.28% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is -48.32% vs -14.86% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is 18.44% vs -17.58% in Mar 2024
Compare Profit and Loss Results of Novartis India
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
356.00
1,735.00
-1,379.00
-79.48%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
356.00
1,735.00
-1,379.00
-79.48%
Expenditure (Ex Depriciation)
Stock Adjustments
3.00
-33.00
36.00
109.09%
Raw Materials Consumed
199.00
830.00
-631.00
-76.02%
Power & Fuel Cost
0.00
106.00
-106.00
-100.00%
Employee Cost
18.00
287.00
-269.00
-93.73%
Operating Expenses
8.00
78.00
-70.00
-89.74%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
10.00
73.00
-63.00
-86.30%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
9.00
21.00
-12.00
-57.14%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
264.00
1,481.00
-1,217.00
-82.17%
Operating Profit (PBDIT) excl Other Income
91.00
253.00
-162.00
-64.03%
Other Income
41.00
40.00
1.00
2.50%
Operating Profit (PBDIT)
133.00
294.00
-161.00
-54.76%
Interest
0.00
7.00
-7.00
-100.00%
Profit before Depriciation and Tax
132.00
287.00
-155.00
-54.01%
Depreciation
2.00
108.00
-106.00
-98.15%
Profit Before Taxation & Exceptional Items
130.00
178.00
-48.00
-26.97%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
130.00
182.00
-52.00
-28.57%
Provision for Tax
29.00
19.00
10.00
52.63%
Profit After Tax
100.00
162.00
-62.00
-38.27%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
728.00
2,279.00
-1,551.00
-68.06%
Profit Available for appropriations
829.00
2,442.00
-1,613.00
-66.05%
Appropriations
829.00
2,442.00
-1,613.00
-66.05%
Equity Dividend (%)
500%
0%
500.00
Earnings Per Share
40.87
23.15
17.72
76.54%
Profit And Loss - Net Sales
Net Sales 356.27 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 6.33% vs -11.53% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 91.42 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 40.09% vs 0.28% in Mar 2024
Profit And Loss - Interest
Interest 0.77 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -48.32% vs -14.86% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 100.90 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 18.44% vs -17.58% in Mar 2024






